Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Pharming Group NvPHAR | $9.82 | Strong Buy | $38.00 | +286.97% | 18 hours ago | |
Analyst RankingTop 6% #306 out of 5342 analysts Average Return+23.56% Win Rate48%66 out of 138 Risk vs RewardPoor Good Analyst ColorCanaccord Genuity's Whitney Ijem raised their price target on Pharming Group NV (NASDAQ: PHAR) by 2.7% from $37 to $38 on 2026/08/04. The analyst maintained their Strong Buy rating on the stock. Pharming Group NV reported its Q2 2026 earnings. Raising their price target, Ijem decribed the quarter's results as "mixed," citing a Ruconest miss and a slight Joenja beat. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.